Clinical Trials Directory

Trials / Completed

CompletedNCT01623765

Lung Cancer Diagnosis and Staging Using Ultrasound Guidance

Diagnosis and Staging of Lung Cancer Using Minimally Invasive Technique With Ultrasound Guidance

Status
Completed
Phase
Study type
Observational
Enrollment
680 (actual)
Sponsor
Singapore General Hospital · Academic / Other
Sex
All
Age
21 Years – 100 Years
Healthy volunteers
Not accepted

Summary

To collect data of all patients who have undergone Endobronchial ultrasound for diagnosis or staging of suspected lung cancer

Detailed description

Introduction: Endobronchial Ultrasound (EBUS) is a procedure that is performed via flexible bronchoscopy under moderate sedation for visualization of lymph nodes in the chest and biopsy under real-time guidance for the staging of lung cancer or evaluation of enlarged lymph nodes. In addition, lung lesions or masses can be visualized and biopsied in the same sitting. The use of EBUS has enhanced the safety and diagnostic yield of flexible bronchoscopy. Aim: The data of patients with suspected lung cancer or undiagnosed lymph node enlargement in whom bronchoscopy with EBUS guidance is clinically indicated will be collected prospectively. Results from EBUS are considered positive if a specific diagnosis is obtained ( eg malignancy) or if lymphocytes are present in the lymph node biopsy, indicating accurate sampling of lymph node. In patients with non-diagnostic EBUS, the results from other procedures will be compared for analysis.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2012-06-20
Last updated
2019-09-19

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT01623765. Inclusion in this directory is not an endorsement.